SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies

The SARS-CoV-2 (COVID-19) pandemic has attracted attention to the challenge of neuroinflammation as an unavoidable component of viral infections. Acute neuroinflammatory responses include activation of resident tissue macrophages in the CNS followed by release of a variety of cytokines and chemokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Putilina, M. V., Grishin, D. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219508/
https://www.ncbi.nlm.nih.gov/pubmed/34176996
http://dx.doi.org/10.1007/s11055-021-01108-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219508/
https://www.ncbi.nlm.nih.gov/pubmed/34176996
http://dx.doi.org/10.1007/s11055-021-01108-z

Ejemplares similares